Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394661
Status:
RECRUITING
Last Update Posted:
2024-05-01
First Post:
2024-04-28
Brief Title:
Serplulimab Plus Chemotherapy for Early-stage ERHER2- Breast Cancer
Sponsor:
Organization:
Henan Cancer Hospital